Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 12 April

Jessica Amir
April 12, 2021

Weekly Wrap 9 April

Jessica Amir
April 9, 2021

Morning Bell 9 April

Jessica Amir
April 9, 2021

Morning Bell 8 April

Jessica Amir
April 8, 2021

Morning Bell 7 April

Jessica Amir
April 7, 2021

Morning Bell 6 April

Jessica Amir
April 6, 2021

Morning Bell 1 April

Jessica Amir
April 1, 2021

Morning Bell 31 March

Jessica Amir
March 31, 2021

Morning Bell 30 March

Jessica Amir
March 30, 2021

Morning Bell 29 March

Bell Direct
March 29, 2021

Weekly Wrap 26 March

Jessica Amir
March 26, 2021